CompaniesByCap
RNTX
Rein Therapeutics Inc. (RNTX)
NASDAQ · Healthcare

Rein Therapeutics Inc. Income Statement 2015–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Revenues
Revenue00000000000
Gross Profit
Profitability
Operating Income-50.6M-65.1M-16.3M-27.6M-26.6M-20.5M-30.0M-31.9M-23.0M-18.2M-12.9M
EBITDA-50.6M-65.0M-16.2M-27.5M-26.5M-20.3M-29.8M-31.7M-22.9M-17.9M-12.6M
Net Income-49.9M-62.9M-15.7M-27.3M-26.2M-27.3M-29.4M-31.5M-22.6M-18.1M-12.9M
Per Share Data
EPS (diluted)$-1.96$-3.51$-3.42$-6.02$-5.89
Shares Outstanding (dil.)25M18M5M5M4M44M28M15M15M0M

Rein Therapeutics Inc. Income Statement — FAQ

Rein Therapeutics Inc. (RNTX) income statement over the last 11 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see RNTX's income statement history?

The chart and table above show Rein Therapeutics Inc.'s income statement by year and by quarter, including the growth rate.